- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Tyrosine Kinase Inhibitor gefitinib (Iressa)
Total 8124 results
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States, Canada, United Kingdom, Australia
-
Institute of Cancer Research, United KingdomActive, not recruitingNSCLCUnited Kingdom, France, Switzerland, Italy, Spain
-
Sun Yat-sen UniversityShenzhen People's Hospital; Sixth Affiliated Hospital, Sun Yat-sen University; Dongguan People's Hospital and other collaboratorsNot yet recruiting2-year Disease-Free SurvivalChina
-
AIO-Studien-gGmbHAstraZenecaTerminatedNSCLC | Non-squamous Non-small Cell Lung Cancer Stage II | Non-squamous Non-small Cell Lung Cancer Stage IIIA | Non-squamous Non-small Cell Lung Cancer Stage IIIB | Activating EGFR MutationGermany
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
National Cancer Institute (NCI)CompletedHead and Neck CancerUnited States
-
IRCCS Azienda Ospedaliera Universitaria San Martino...UnknownNon Small Cell Lung CancerItaly
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMantle Cell LymphomaUnited States
-
Peking Union Medical College HospitalUnknownNon Small Cell Lung CancerChina
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteIncyte Corporation; H. Jean Khoury Cure CML ConsortiumRecruitingChronic Myeloid Leukemia, Chronic Phase | Chronic Phase Chronic Myeloid LeukemiaUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); Boehringer IngelheimCompletedRecurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Stage III Non-small Cell Lung CancerUnited States
-
Guangdong Association of Clinical TrialsPeking University First Hospital; Zhejiang Cancer Hospital; Peking University... and other collaboratorsUnknownNon-small Cell Lung CancerChina
-
AstraZenecaWithdrawnMetastatic Colorectal CancerItaly
-
AstraZenecaCompletedNon-Metastatic Prostate CancerFinland
-
Gachon University Gil Medical CenterCompletedPrevious Treated Metastatic Non-small Cell Lung CancerKorea, Republic of
-
Qilu Pharmaceutical Co., Ltd.UnknownNon-small-cell Lung CancerChina
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedRecurrent Pleural Malignant Mesothelioma | Stage IV Pleural MesotheliomaUnited States
-
National University Hospital, SingaporeNational Healthcare Group, SingaporeCompletedNasopharyngeal CarcinomaSingapore
-
Amsterdam UMC, location VUmcTerminated
-
AstraZenecaCompletedBreast CancerSweden, Norway, Denmark
-
European Organisation for Research and Treatment...TerminatedLung CancerItaly, Netherlands, Egypt, Belgium, Cyprus
-
Zhejiang Cancer HospitalUnknownEsophageal CancerChina
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingChronic Phase Chronic Myeloid Leukemia, BCR-ABL1 PositiveUnited States, Canada, Australia, Puerto Rico
-
Tian XieLinkDoc Technology (Beijing) Co. Ltd.RecruitingAdenocarcinoma | Carcinoma | Non-Small-Cell Lung CancerChina
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Endometrial Adenocarcinoma | Endometrial Transitional Cell Carcinoma | Endometrial Mucinous Adenocarcinoma | Endometrial Squamous Cell Carcinoma | Malignant Uterine Corpus Mixed Epithelial and Mesenchymal NeoplasmUnited States
-
Beijing 302 HospitalRecruiting
-
Emory UniversityTerminatedRecurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedColorectal CancerUnited States
-
The University of Texas Health Science Center at...National Cancer Institute (NCI)CompletedColorectal CancerUnited States
-
AstraZenecaCompletedCancer of Head and NeckSpain
-
AstraZenecaCompletedCancer of Head and Neck | Squamous Cell CancerUnited Kingdom
-
Zhejiang UniversityUnknownNon Small Cell Lung CancerChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingChronic Lymphocytic Leukemia | Autoimmune Hemolytic Anemia | Warm Antibody Autoimmune Hemolytic Anemia | Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUnited States
-
AstraZenecaCompleted
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Sameek RoychowdhuryActive, not recruiting
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Janssen Scientific Affairs, LLCActive, not recruitingStage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Contiguous Stage II Mantle Cell Lymphoma | Noncontiguous Stage II Mantle Cell Lymphoma | Stage I Mantle Cell LymphomaUnited States
-
Kami Maddocks, MDActive, not recruitingRecurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory/Relapsed Chronic Lymphocytic LeukemiaUnited States
-
Anhui Medical UniversityUnknownSelf Efficacy | Drug ToxicityChina
-
Roswell Park Cancer InstituteNational Comprehensive Cancer NetworkCompletedCarcinoid Tumor | Neuroendocrine Neoplasm | Metastatic Carcinoid TumorUnited States
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversitySuzhou Suncadia Biopharmaceuticals Co., Ltd.RecruitingBiliary Tract Cancer | Gemox ChemotherapyChina
-
Guangdong Association of Clinical TrialsChanghai Hospital; First People's Hospital of Hangzhou; Fudan University; Henan... and other collaboratorsCompletedNon-small Cell Lung CancerChina
-
AstraZenecaActive, not recruitingNon-Small Cell Lung CancerDenmark, Italy, Spain, United States, Korea, Republic of, Japan, Netherlands, Norway, Sweden
-
National Cancer Centre, SingaporeNovartisCompleted